简介：Followingthepolicyofreformandstepstoopenup,rapideconomicdevelopmenthasbeenaccompaniedbypromotionofcommunications,science,technology,andculture.Inthisperiod,Chinesemedicalworkershaveachievedagreatdealinscientificresearch,bothbasicandclinical.Itseemsespeciallyimportantthatweunder

简介：The2016revisionofthe“ChineseGuidelinesonPreventionandTreatmentofDyslipidemiainAdults”istheoutcomeofthejointeffortsofthemembersofanexpertpanelformorethan1year,andisbasedonthe2007guidelines.Thereisnodoubtthatthereleaseofthe2007guidelinesgreatlyfacilitatedthemanagementofdyslipidemiaandthepreventionandtreatmentofatheroscleroticcardiovasculardiseases(ASCVDs)inChina.However,anupdateoftheguidelinesforthemanagementofdyslipidemiainChineseadultsisurgentlyneededsincehugechangeshaveoccurredintheconceptsofdyslipidemiaresearchandcontrolduringthelastdecade.

简介：Developinganewjournalisnotaneasytask.Icanthinkoffourgoodreasons,andthereareprobablymore.Thesereasonsareasfollows:1.Potentialauthorsmaybereluctanttosendmanuscriptstoanunknown"newjournal."2.Potentialauthorsmaybeconcernedaboutthelackofan"impactfactor."3.Potentialauthorsmayhaveconcernsaboutreadershipoftheauthors'work.4.Potentialreviewersmaybereluctanttoreviewmanuscriptssenttoanewjournalbecausemosthavemultiplemanuscriptstoreviewsenttothemfromknownjournals.

简介：Despitethehugedevelopmentofradiofrequencycatheterablation,surgicaloperation,pacemakerimplantation,anddrugtherapyremainsthefirstlinetreatmentofatrialfibrillation.Severalnewanti-arrhythmicdrugsandanticoagulationdrugshavecomeoutrecently,andhavemadethedrugtherapyofatrialfibrillationamorepromisingchoice.Thisarticleprovidesacontemporaryhighlightonthenewanti-arrhythmicagentsofatrialfibrillation.

简介：Chronicheartfailureisincreasinglyprevalentworldwideandisassociatedwithsignificantmorbidityandmortality.TheCochranereviewdemonstratedthatcardiacrehabilitation(CR)resultedinimprovementsinQOLandareductioninlong-termmortality.Chronickidneydisease(CKD)isanotherworldwidepublichealthproblem.ThisreviewfocusesontheimportanceandefficacyofrehabilitationforCKDpatientsasanewtargetofCR.PatientswithCKDonhemodialysis(HD)haveahighmortalityrate,withcardiovasculardiseases,suchaschronicheartfailure.Anewsystematicreviewandmeta-analysisofrandomizedcontrolledtrialsreportedthatexercise-basedrenalrehabilitationimprovedaerobiccapacity,muscularfunctioning,cardiovascularfunction,walkingcapacity,andQOLinCKDpatientswithHD.Moreover,exercisetrainingmayhaverenalprotectiveeffects,notonlyinsomeanimalmodelsofpre-HDCKD,butalsoinpre-HDCKDpatients.Exercisetherapycouldbeaneffectiveclinicalstrategyinimprovingrenalfunction,loweringtheneedforrenalreplacementtherapy,suchasHD,andreducingrenaltransplantriskinpre-HDCKDpatients.ThisledtheMinistryofHealth,LaborandWelfareofJapantoextendrenalrehabilitationpartialcoveragetostage4pre-HDCKDpatientsforthefirsttimeintheworldin2016.

简介：BackgroundMicroRNAshaverecentlybeenconsideredasbiomarkersinseveraldifferentcardiovasculardiseases,however,sofartherearenocirculatingmiRNAsdataabouthypertension.Therefore,theaimofthepresentpilotstudywastoidentifycirculatingmiRNAsforhypertensionbiomarkers.MethodsUsinganAgilentmicroarray,plasmamiRNAswereprofiledfromplasmasamplesof10patientswithuntreatedessentialhypertensionand10healthycontrols.CandidatebiomarkersidentifiedintheprofilesweresubjectedtovalidationbyusingquantitativePCRinanindependentsamplesetof20patientswithuntreatedessentialhypertensionand20healthycontrols.Then,weassessedtheselectedmiRNAsforthedetectionanddiagnosisofhypertensionfromplasmasamplesof70patientswithuntreatedessentialhypertensionand20healthycontrols.TheSpearmancorrelationcoefficientwasusedtoassessedtheselectedmiRNAscorrelationswithbloodpressure.Theareaunderthereceiveroperatingcharacteristiccurve(AUC)wasusedtoevaluatediagnosticaccuracy.ResultsTheexpressionsofselected8miRNAswereinvestigatedindependentlyinplasmasamplesfrom10hypertensionpatientsand10healthysubjects.ThelevelsofcirculatingmiR-30c-5p,miR-133b,miR-29b-3p,miR-29a-3p,miR-29c-3p,miR-30a-3p,miR-let7b-3pexpressionweresignificantlydownregulatedinhypertensiongroupcomparedwithhealthygroupandthelevelofhsa-miR-92b-3pwassignificantlyunregulatedbetweenthegroups.WeusedqRT-PCRassaytoconfirmtheexpressionof8candidatemiRNAs,miR-30c-5p(P<0.001),miR-29b-3p(P<0.001),miR-29a-3p(P=0.027),miR-29c-3p(P<0.001),miR-92b-3p(P=0.003),miR-30a-3p(P=0.704),miR-133b(P=0.346),andmiR-let7b(P=0.161).ThediagnosticaccuracyofmiR-30c-5p,miR-29b-3p,miR-29a-3p,miR-29c-3pandmiR-92b-3p,asmeasuredbyAUC,were0.897,0.90,0.829,0.825and0.832,respectively,withallP<0.001.ConclusionsTheplasmalevelsofmiR-30c-5p,miR-29b-3p,miR-29a-3p,miR-29c-3pandmiR-92b-3passociatedwithhypertensionwhichprovideanimp

简介：Atrialfibrillation(AF)isthemostcommoncardiacarrhythmiaaffectingmillionsofpeopleworldwidewithincreasingincidenceandprevalence.RadiofrequencycatheterablationhasevolvedasthetreatmentofchoiceforbothparoxysmalandpersistentAF.Severalstudieshavebeenreportedoncatheterablationasthefirst-linetreatmentforparoxysmalAFanddifferentstrategiesforpersistentAF.Newtechnologiessuchascontact-forcesensingcathetersandcryoballoonhavebeenrecentlyusedandtheprocedurecarriestheriskofcomplicationslikehematoma,arteriovenousfistula,cardiactamponade,pulmonaryveinstenosis,atrio-esophagealfistulaanddeath.

简介：Beforethe1950s,D-transpositionofthegreatarterieswasassociatedwithnearly90%mortalitywithinthefirstyearoflife.TheMustardandSenningproceduresresultedinasignificantincreaseinthelifespanofthesepatientsbutwithnotablelong-termcomplications,includingarrhythmias,sinusnodedysfunction,chronotropicincompetence,andrightventricularsystolicdysfunction.Thearterialswitchoperation(firstdescribedbyAdibJatene)initiallyresultedinnearlyuniversaldeath.However,theuseofcoronarybuttonsforcoronaryarterytranslocationhasimprovedoperativesurvivaldramatically.Itisnowconsideredthetreatmentofchoiceinpatientsamendabletothearterialswitchoperation.Consideredananatomicrepair,resultinginconcordantventriculoarterialconnectionsandasystemicleftventricle,thearterialswitchoperationreducestheincidenceofventriculardysfunction.However,itisalsoassociatedwithlong-termcomplications,includingaorticrootdilatation,aorticvalveregurgitation,rightventricularoutflowtractobstructions,coronaryarterystenosis/compression,andbranchpulmonaryarterystenosis.

简介：Despitethedevelopmentofnoninvasivetoolsasechocardiography,right-sidedheartcatheterizationremainsanintegralpartofthecardiovascularevaluation.Inthelastdecade,betterunderstandingofthehemodynamicprocessbeforeheartfailuredecompensationledtoimprovementofoutpatientstrategiestopreventit.Advancesinimplantablewirelesstechnologynowallowfrequentanddirectmeasurementofintracardiacfillingpressures,whichcanbemonitoredbyhealthcareproviderstohelptailortherapytoreducefillingpressuresandhospitalreadmissionrates.

简介：In2014theAmericanCollegeofCardiology/AmericanHeartAssociationissuedfournewguidelinesforcardiovasculardiseasepreventionthatfocusedoncardiovascularriskassessment,lifestylemanagement,obesitymanagement,andbloodcholesterolmanagement.Thedevelopmentofanatheroscleroticcardiovasculardiseaseriskcalculatorformedthebasisoftheriskassessmentguideline,andthelifestylemanagementguidelinefocusedonrecommendinganevidence-baseddietarypattern.Thebloodcholesterolmanagementguidelinespecificallyidentifiedfourgroupsofpatientsshowntobenefitfrommoderate-intensityorhigh-intensitystatintherapyfrompreviousclinicaltrialsandabandonedtheuseofspecificlow-densitylipoprotein(LDL)cholesterol(LDL-C)goallevelsonthebasisofthelackofclinicaltrialevidence.Therecommendationsfortreatmentwithmoderate-intensityorhigh-intensitystatintherapyarebasedonrigorousevidencefromrandomizedclinicaltrials.Guidancehassincebeenprovidedfortheuseofnonstatintherapies,includingcholesterolabsorptioninhibitorandproproteinconvertasesubtilisin/kexintype9monoclonalantibodytherapywhenadequatereductionofLDL-Clevelsisnotachievedwithmaximallytoleratedstatintherapy.TherecentdevelopmentandapplicationofthesetherapieshaveresultedinremarkablereductionsinLDL-Clevelsthatarewelltolerated,andpreliminaryoutcomedataarepromisinginshowingsubstantialatheroscleroticcardiovasculardiseaseeventreductionsbeyondstatintherapy.

简介：Inspiteofrecentadvancesintreatmentandcontrol,theprevalenceofCVDandpulmonaryhypertension(PH)aroundtheworldhasincreasedsignificantly.Webelievethataconceptualbreakthroughisneededandnoveldrugtargetsmustbediscoveredinanattempttocontrolandtreatthem.ACE2,thenewestmemberoftherenin-angiotensinsystem(RAS),appearstoholdthispotential.Ourstudieshaveestablishedanovelconcept:abalancebetweenthevasodeleteriousaxis(ACE/AngⅡ/ATlR)andthevasoprotectiveaxis(ACE2/Ang-1-7/Mas)oftheRASiscriticalinmaintainingnormalCVfunctionsandanyimbalanceinitiatesvasculardysfunctionsleadingtocardiopulmonarydiseases.ThuswehypothesizethatACE2,whichisakeyenzymeindecreasingAngⅡandincreasingAng-1-7,wouldbeanidealforconsiderationasatherapeutictarget.Theobjectiveofmypresentationwillbetopresentevidenceinsupportofthisconcept.ThedatapresentedwilldemonstratethatoverexpressionofACE2bygeneticmeansoritsactivationbenovelACE2activatorsproteststheheartfromhypertension-andMi-inducedcardiacdamage.Also,thisstrategyisextremelyeffectiveinpreventionandreversalofPHandpulmonaryfibrosis.Astructure-baseddrugdiscoveryapproachwillbepresentedtoidentifysmallmoleculeACE2acti-vatorsandtheirpotentialinproducingbeneficialoutcomesonCVDandpulmonaryhypertensionwillbediscussed.

简介：In2003,IwasinvitedtoattendandpresentascientificpaperattheGWICCmeetinginBeijing,China,byProfessorHuDayi.AtthetimeProfHuwaschiefofcardiologyinBeijingandDeanofamedicalschoolinShanghai.ThisconferencewasandstillisthelargestcardiologyeducationalandscientificprograminChinaandisattendedbymorethantenthousandpersons,mostlyChinese,butalsoEuropeans,Americans,andothernationalities.